Jagiellonian University, Faculty of Chemistry, Kraków, Poland.
J Enzyme Inhib Med Chem. 2011 Jun;26(3):309-18. doi: 10.3109/14756366.2010.504675. Epub 2010 Aug 9.
In this work, we studied the behaviours of urease in the presence of l-ascorbic acid (AA) and dehydroascorbic acid (DHA) in different conditions. The inactivations of urease were carried out in an unbuffered and buffered system. We show that in the unbuffered system AA inactivated urease in a biphasic manner by denaturation brought about by AA-lowered pH. Further, we show that in the buffered system neither AA nor DHA themselves are inhibitors of urease. The inhibitory action of AA and DHA was revealed in the presence of Fe(3+) ions and most importantly, unlike reported in the literature, it was found to be primarily mediated by H(2)O(2). The resulting inhibition by DHA-Fe(3+) consisted of enzyme thiol oxidation and its effectiveness grew with increasing pH. The results may shed light on the roles of AA in therapies applied in ureolytic bacteria infections, notably those with Helicobacter pylori.
在这项工作中,我们研究了脲酶在抗坏血酸(AA)和脱氢抗坏血酸(DHA)存在下的不同条件下的行为。在无缓冲和缓冲系统中进行脲酶失活。我们表明,在无缓冲系统中,AA 通过 AA 降低 pH 引起的变性以两相方式失活脲酶。此外,我们表明在缓冲系统中,AA 和 DHA 本身都不是脲酶的抑制剂。在 Fe(3+)离子存在下,AA 和 DHA 的抑制作用被揭示出来,最重要的是,与文献中的报道不同,它主要是由 H(2)O(2)介导的。DHA-Fe(3+)的抑制作用包括酶巯基氧化,其有效性随 pH 值的增加而增加。这些结果可能揭示了 AA 在用于脲酶细菌感染的治疗中的作用,特别是在幽门螺杆菌感染中的作用。